# Mark W. Kieran

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-w-kieran/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,232 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 93 |
| i10-index | 272 |
| Last Known Institution | NGM Biopharmaceuticals (United States) |
| OpenAlex ID | https://openalex.org/A5060208068 |
| ORCID iD | https://orcid.org/0000-0003-2184-7692 |
| Works | 558 |

## Researcher papers

- [A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors](https://scholariq.org/papers/a-small-molecule-antagonist-of-cxcr4-inhibits-intracranial-growth-of-primary/)
- [Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas](https://scholariq.org/papers/exome-sequencing-identifies-braf-mutations-in-papillary-craniopharyngiomas/)
- [Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma](https://scholariq.org/papers/recurrent-somatic-mutations-in-acvr1-in-pediatric-midline-high-grade-astrocytoma/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Neurofibromatosis and Schwannoma Cases](https://scholariq.org/topics/neurofibromatosis-and-schwannoma-cases/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

## Researcher university

- [NGM Biopharmaceuticals (United States)](https://scholariq.org/institutions/ngm-biopharmaceuticals-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.